Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. SELLAS Life Sciences Group Inc’s current trading price is -16.04% away from its 52-week high, while its distance from the 52-week low is 130.57%. The stock’s price range during this period has varied between $0.77 and $2.12. The company, active in the Healthcare sector, saw a trading volume of around 2.38 million for the day, considerably higher average daily volume of 1.75 million observed over the last three months.
The market performance of SELLAS Life Sciences Group Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $2.12 on 05/27/25, with the lowest value for the same timeframe being $0.77, recorded on 12/13/24.
How Financial Performance Impacts Market Capitalization
SELLAS Life Sciences Group Inc (SLS) has experienced a quarterly rise of 54.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 177.60M and boasts a workforce of 15 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2920, with a change in price of +0.7400. Similarly, SELLAS Life Sciences Group Inc recorded 2,449,451 in trading volume during the last 100 days, posting a change of +71.15%.
How SLS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SLS stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
SLS Stock Stochastic Average
As of today, the raw stochastic average of SELLAS Life Sciences Group Inc over the past 50 days is 70.94%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 55.26%. Additionally, the Stochastic %K and %D values for the company were 68.42% and 70.80%, respectively, over the past 20 days.
SLS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant gain of 71.15% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 45.90%. Over the past 30 days, the price of SLS has fallen by 26.24%. And in the last five days, it has fallen by -8.25%.
